Phase III Trial of Topical Formulation of Sirolimus to Skin Lesions in Patients With Tuberous Sclerosis Complex (TSC)
Status:
Completed
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to evaluate the efficacy and safety of NPC-12G gel (topical
formulation of sirolimus) versus placebo gel to facial angiofibroma and other skin lesions in
patients with tuberous sclerosis complex (TSC)